News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
856,819 Results
Type
Article (87153)
Company Profile (704)
Press Release (768941)
Multimedia
Podcasts (160)
Webinars (24)
Section
Business (232946)
Career Advice (4136)
Deals (39776)
Drug Delivery (132)
Drug Development (91174)
Employer Resources (200)
FDA (18237)
Job Trends (17382)
News (397120)
Policy (39878)
Tag
Academia (3002)
Academic (2)
Accelerated approval (16)
Adcomms (33)
Allergies (111)
Alliances (56979)
ALS (130)
Alzheimer's disease (1633)
Antibody-drug conjugate (ADC) (199)
Approvals (18221)
Artificial intelligence (440)
Autoimmune disease (40)
Automation (22)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (145)
Biotechnology (482)
Bladder cancer (111)
Brain cancer (45)
Breast cancer (425)
Cancer (3396)
Cardiovascular disease (289)
Career advice (3548)
Career pathing (34)
CAR-T (224)
CDC (43)
Cell therapy (614)
Cervical cancer (28)
Clinical research (74741)
Collaboration (1225)
Company closure (4)
Compensation (809)
Complete response letters (45)
COVID-19 (2929)
CRISPR (72)
C-suite (451)
Cystic fibrosis (128)
Data (3501)
Decentralized trials (2)
Denatured (57)
Depression (89)
Diabetes (399)
Diagnostics (7026)
Digital health (28)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (204)
Drug pricing (168)
Drug shortages (36)
Duchenne muscular dystrophy (175)
Earnings (98607)
Editorial (52)
Employer branding (25)
Employer resources (169)
Events (132108)
Executive appointments (942)
FDA (20385)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1089)
Gene editing (156)
Generative AI (43)
Gene therapy (484)
GLP-1 (980)
Government (5330)
Grass and pollen (7)
Guidances (329)
Healthcare (20933)
HIV (47)
Huntington's disease (32)
IgA nephropathy (50)
Immunology and inflammation (202)
Immuno-oncology (17)
Indications (44)
Infectious disease (3140)
Inflammatory bowel disease (175)
Inflation Reduction Act (13)
Influenza (84)
Intellectual property (150)
Interviews (814)
IPO (17916)
IRA (59)
Job creations (5195)
Job search strategy (2863)
Kidney cancer (15)
Labor market (66)
Layoffs (617)
Leadership (30)
Legal (10143)
Liver cancer (88)
Longevity (12)
Lung cancer (476)
Lymphoma (243)
Machine learning (17)
Management (65)
Manufacturing (527)
MASH (114)
Medical device (14801)
Medtech (14815)
Mergers & acquisitions (22653)
Metabolic disorders (1032)
Multiple sclerosis (109)
NASH (23)
Neurodegenerative disease (174)
Neuropsychiatric disorders (49)
Neuroscience (2479)
NextGen: Class of 2025 (7687)
Non-profit (5094)
Now hiring (54)
Obesity (522)
Opinion (300)
Ovarian cancer (110)
Pain (141)
Pancreatic cancer (139)
Parkinson's disease (210)
Partnered (27)
Patents (368)
Patient recruitment (235)
Peanut (55)
People (65949)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23046)
Phase II (32448)
Phase III (24440)
Pipeline (2352)
Policy (274)
Postmarket research (3554)
Preclinical (10403)
Press Release (72)
Prostate cancer (165)
Psychedelics (48)
Radiopharmaceuticals (280)
Rare diseases (581)
Real estate (7405)
Recruiting (76)
Regulatory (27556)
Reports (64)
Research institute (2670)
Resumes & cover letters (650)
Rett syndrome (11)
RNA editing (14)
RSV (62)
Schizophrenia (113)
Series A (180)
Series B (131)
Service/supplier (30)
Sickle cell disease (74)
Special edition (24)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4313)
State (2)
Stomach cancer (17)
Supply chain (90)
Tariffs (81)
The Weekly (101)
Vaccines (985)
Venture capital (63)
Weight loss (359)
Women's health (54)
Worklife (20)
Date
Today (64)
Last 7 days (508)
Last 30 days (2640)
Last 365 days (34094)
2025 (22358)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (75)
Alaska (7)
Arizona (290)
Arkansas (14)
Asia (50733)
Australia (8909)
California (8613)
Canada (2629)
China (807)
Colorado (365)
Connecticut (385)
Delaware (235)
Europe (116469)
Florida (1282)
Georgia (295)
Hawaii (3)
Idaho (67)
Illinois (776)
India (43)
Indiana (419)
Iowa (19)
Japan (256)
Kansas (121)
Kentucky (35)
Louisiana (20)
Maine (75)
Maryland (1190)
Massachusetts (6534)
Michigan (290)
Minnesota (529)
Mississippi (4)
Missouri (111)
Montana (32)
Nebraska (26)
Nevada (96)
New Hampshire (75)
New Jersey (2384)
New Mexico (31)
New York (2360)
North Carolina (1327)
North Dakota (10)
Northern California (3809)
Ohio (273)
Oklahoma (17)
Oregon (49)
Pennsylvania (1820)
Puerto Rico (18)
Rhode Island (42)
South America (1654)
South Carolina (43)
South Dakota (1)
Southern California (3244)
Tennessee (138)
Texas (1347)
United States (32156)
Utah (257)
Virginia (234)
Washington D.C. (82)
Washington State (740)
West Virginia (4)
Wisconsin (90)
There are 856,819 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Supercharging Antibody Drug Discovery with AI: The Rise of Chai-2 and Patsnap’s Lao Tzu Dataset
September 2, 2025
·
1 min read
FDA
Offit Out at FDA Vaccine Advisory Committee After HHS Rebuff
Paul Offit, longtime member of the FDA’s vaccine advisory committee and an outspoken critic of Health Secretary Robert F. Kennedy Jr., was recently informed by the Department of Health and Human Services that his services are no longer required.
September 2, 2025
·
3 min read
·
Heather McKenzie
Press Releases
American Aires Inc. Announces Business Continuity and Governance Actions Following Special Committee Review
September 2, 2025
·
7 min read
Press Releases
Defence Therapeutics Engages Dr. Amie Phinney as Strategy & Business Advisor to Guide Next Phase of Growth
September 2, 2025
·
4 min read
Press Releases
Medicus Pharma Ltd. Completes Acquisition of Antev Limited
Antev is developing Teverelix, a next generation GnRH Antagonist, as a first in class market product for Acute Urinary Retention (AURr) and high CV risk Prostate Cancer collecting representing ~US$6 billion in potential market opportunityPatrick J. Mahaffy, a veteran pharma executive and the former Chairman of Antev, appointed to Medicus Board of Directors
September 2, 2025
·
10 min read
Press Releases
Aires Announces Record Q2 2025 Revenue of $6.0 Million & 115% YoY Sales Growth
September 2, 2025
·
12 min read
Press Releases
Soricimed Biopharma Inc. Strengthens Executive Team with Appointment of Dr. Michael Groaning PhD, as Chief Scientific Officer
September 2, 2025
·
3 min read
Press Releases
OS Therapies Completes Exercise Inducement and Exchange Offer for All Remaining Outstanding Warrants Issued in Connection with December 2024 Financing
All remaining holders of outstanding warrants with $1.12 per share exercise price have participated, raising $3.7 million in gross proceeds to be used to accelerate OST-HER2 commercial launch preparations New warrants issued have an exercise price of $3.00 per share with a forced exercise provision when the stock trades above $9.00
September 2, 2025
·
5 min read
Press Releases
OS Therapies Provides OST-HER2 Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma Program Update Following FDA End of Phase 2 Meeting
Company on track to begin submission of a rolling Biologics Licensing Application (BLA) request for OST-HER2 to U.S. Food & Drug Administration in September 2025
September 2, 2025
·
9 min read
Press Releases
BioHarvest Sciences to Host a Virtual Investor Webinar on September 10, 2025 at 1:00 PM ET
September 2, 2025
·
3 min read
1 of 85,682
Next
